Sandra Suderman
Family · Bonner Springs, KSNPI 1679666077
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$845
- Lilly USA, LLC$607
- AstraZeneca$484
- Pfizer$290
- Abbott$213
- Novo Nordisk$176
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $845 |
| Lilly USA, LLC | 29 | $607 |
| AstraZeneca(2 entities) | 25 | $484 |
| Pfizer | 20 | $290 |
| Abbott | 13 | $213 |
| Novo Nordisk | 10 | $176 |
| Otsuka America Pharmaceutical, Inc. | 5 | $130 |
| Boehringer Ingelheim | 7 | $120 |
| Dexcom, Inc. | 5 | $89 |
| Amgen | 4 | $83 |
| GSK | 4 | $83 |
| Shield Therapeutics Inc | 1 | $72 |
| Novartis | 3 | $52 |
| Astellas Pharma US Inc | 2 | $51 |
| Inspire Medical Systems, Inc. | 2 | $50 |
| Ardelyx, Inc. | 2 | $46 |
| Exact Sciences | 3 | $45 |
| Johnson & Johnson | 2 | $37 |
| Dermavant Sciences, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $33 |
| Boston Scientific | 1 | $28 |
| Noven Therapeutics, LLC | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Medtronic | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
How this compares
$3,662 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 56 | $67,235 |
| EliquisApixaban | 32 | $32,392 |
| JanuviaSitagliptin Phosphate | 23 | $29,309 |
| OzempicSemaglutide | 13 | $22,967 |
| JardianceEmpagliflozin | 18 | $18,636 |
| TrulicityDulaglutide | 12 | $11,390 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $8,371 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $8,338 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $4,945 |
| PremarinEstrogens, Conjugated | 13 | $3,431 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 118 | $3,333 |
| Levothyroxine Sodium | 285 | $2,492 |
| Gabapentin | 173 | $2,462 |
| Diclofenac Sodium | 38 | $2,290 |
| Atorvastatin Calcium | 246 | $2,186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $607 | $78,62568 claims |
| PfizerEliquis, Premarin | $290 | $35,82345 claims |
| Novo NordiskOzempic | $176 | $22,96713 claims |
| Boehringer IngelheimJardiance | $120 | $18,63618 claims |
| AstraZenecaSymbicort | $484 | $8,33830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,579 family providers in Kansas.
Other family in Bonner Springs
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
- Jaimie HeldstabWestwood$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.